Amélie Faubert, a current McGill-HEC Montréal EMBA participant, recently joined Nexelis as Senior Director, Corporate Development.
Nexelis is an immunology-centric contractual research organization specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing. Nexelis contributes to saving lives by supporting pharmaceutical and biotech companies in the development of vaccines and large molecules.
With a master’s degree in immunology from University of Montreal and a PhD in experimental medicine from McGill University, and her experience working for two pharmaceutical leaders, Servier and Merck, Amélie will undoubtedly be an asset for Nexelis.
“I firmly believe that the EMBA helped me to obtain this position and that all that I’ve learned over the past months will enable me to have a very significant impact, very quickly, in this growing organization.”
